SOCM
SR One Capital Management Portfolio holdings
AUM
$461M
This Quarter Return
-29%
1 Year Return
+23.25%
3 Year Return
+188.96%
5 Year Return
–
10 Year Return
–
AUM
$195M
AUM Growth
+$195M
(+10%)
Cap. Flow
+$77.1M
Cap. Flow
% of AUM
39.48%
Top 10 Holdings %
Top 10 Hldgs %
100%
Holding
3
New
1
Increased
–
Reduced
–
Closed
–
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
1
Design Therapeutics
DSGN
$315M
| $90.9M | 46.52% |
5,626,476
| – | – |
|
2
Arcellx
ACLX
$3.85B
| $77.1M | 39.48% |
+5,500,007
| New | +$77.1M |
|
|
EFTR
3
DELISTED
eFFECTOR Therapeutics, Inc. Common Stock
EFTR
| $27.4M | 14.01% |
6,822,114
| – | – |
|